Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Global Search for Next Antibiotic

June 22, 2015 8:31 am | by University of Queensland | News | Comments

Researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics. Read more...


Tekmira Says Ebola Drug Unlikely to Work in Study

June 22, 2015 8:21 am | by The Associated Press | News | Comments

The Canadian company said the mid-stage study reached a statistical futility boundary. Read more...


TB Bacteria Hide in Low Oxygen Niches of Bone Marrow Stem Cells

June 22, 2015 8:20 am | by Forsyth Institute | News | Comments

A new study is helping to shed light on latent tuberculosis and the bacteria’s ability to hide in stem cells. Read more...


Studying the Evolution of Ebola

June 22, 2015 8:20 am | by University of Bristol | News | Comments

The research team used blood samples taken from patients and compared changes in the genetic material of the virus from throughout the outbreak. Read more...


North Korea Says it Cured Cancer, AIDS, Ebola with Wonder Drug

June 22, 2015 8:20 am | by Seth Augenstein, Digital Reporter | News | Comments

North Korea — which has allegedly starved millions of its people and is unable to treat even modest medical problems such as cataracts — has a new drug on the market that it says can cure AIDS, Ebola and some cancers. Read more...


GlaxoSmithKline Invests $95M in Independent Genetics Institute

June 19, 2015 1:29 pm | by Seth Augenstein, Digital Reporter | News | Comments

GlaxoSmithKline is investing in probing deep into a human cell’s “operating system,” they announced this week. The London-based pharma company is investing $95 million in a new startup called the Altius Institute for Biomedical Sciences in Seattle, they announced. Read more...


Selecta's Synthetic Vaccine Particles Instrumental in Mucosal Vaccines Research

June 19, 2015 12:19 pm | News | Comments

Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies using synthetic vaccine particles (SVP), today announced a publication in the prestigious journal Science describing the use of SVP to create a novel vaccine technology designed to target mucosal tissues. Read more...


Phase 3 Data Show Panitumumab Improves OS in Metastatic Colorectal Cancer

June 19, 2015 11:57 am | News | Comments

Amgen today announced that a Phase 3 study evaluating Vectibix® (panitumumab) and best supportive care (BSC) met its primary endpoint, demonstrating a statistically significant improvement in overall survival (OS) in patients with chemorefractory wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC) compared to those patients treated with BSC alone. Read more...


NIH Funding to Increase $1.1 B – But Popular Agency is Eliminated

June 19, 2015 11:48 am | by Seth Augenstein, Digital Reporter | News | Comments

The National Institutes of Health would get an additional $1.1 billion in next year’s budget, while eliminating a popular agency, according to a House appropriations bill released this week. Read more...


Molecular Cause of Heart Condition Identified by Researchers

June 19, 2015 10:55 am | by Krista Conger, Stanford University | News | Comments

The beta adrenergic pathway is dysfunctional in dilated cardiomyopathy. Now, researchers have learned how a mutation that causes the disease affects the pathway, and how to mitigate its effects. Read more...


U.S. Agrees to Pay Millions for Agent Orange Claims

June 19, 2015 10:46 am | by Hope Yen, Associated Press | News | Comments

Ending years of wait, the government agreed Thursday to provide disability benefits to as many as 2,100 Air Force reservists and active-duty forces exposed to Agent Orange residue on airplanes used in the Vietnam War. Read more...


MRSA Contamination Found in Supermarket Sausages, Mixed Pork

June 19, 2015 9:39 am | by University of Cambridge | News | Comments

In collaboration with the Wellcome Trust Sanger Institute an analysis of the genetic make-up of the bacteria and confirmed the presence of antibiotic resistant genes. Read more...


MedDay Reports Additional Positive Data from Phase 3 Study of Progressive MS Drug

June 19, 2015 9:32 am | News | Comments

The data will be announced on Saturday June 20th at The 1st Congress of the European Academy of Neurology (EAN). Read more...


BiondVax Announces FDA Acceptance of IND Application for Investigational Flu Vaccine

June 19, 2015 9:23 am | News | Comments

This IND continues BiondVax's clinical program, and will allow BiondVax to conduct an FDA approved Phase 2 clinical trial that will involve the administration of M-001, BiondVax's product candidate. Read more...


Dengue Fever Outbreak Infects Thousands in War-Torn Yemen

June 19, 2015 8:49 am | by Ahmed Al-Haj, Associated Press | News | Comments

Thousands of people have been diagnosed with dengue fever in southern Yemen, where fighting has raged for months between Shiite rebels and their opponents, international organizations and health officials said Thursday. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.